COMPLIANCE INFO_1993-2006 - Laserfiche WebLink

Home Browse Search

State of California -Health and Welfare Agencs • Department of Health Services Page 4 of 5 pages RADIOACTIVE MATERIAL LICENSE License Number: 1368-39 Amendment Number: 28 21. Treatment and management of patients receiving therapeutic quantities of unsealed radioactive materials shall be in accordance with guidance contained in Chapter 4, "Release from Hospital of Patients Containing Radioactive Material" National Council on Radiation Protection and Measurements (NCRP) Report No. 37, "Precautions in the Management of Patients Who Have Received Therapeutic Amounts of Radionuclides" (NCRP Publications, P.O. Box 30175, Washington, D.C. 20014). 22. Treatment and management of patients undergoing brachytherapy shall be in accordance with guidance contained in Chapter 5, "Safety Precautions in. Clinical Application", National Council on Radiation Protection and Measurements (NCRP) Report No. 40, "Protection Against Radiation From Brachytherapy Sources" (NCRP Publications, P.O. Box 30175, Washington, D.C. 20014). 23. If there is reason to suspect that a medical radium source may be leaking or contaminated, it shall be tested before further use, by a method acceptable to the Department of Health Services, and a report of the test results and the action taken shall be submitted within 30 days to the Radiologic Health Branch. 24. Notwithstanding the six-month test interval requirement of Section 30275 of Title 17, California Code of Regulations, medical Cesium -137 sources (3M Company Models 6500-6507 or Model 6D6C, and Isotope Products Model 67-800 or 67-820 series) possessed under this license may be tested for leakage and/or contamination at three- year intervals. 25. Production or processing of radiopharmaceuticals for the purpose of commercial distribution to other licensees is not authorized by this license. 26. Radioactive materials shall be used by occupational workers in such a manner that the dose limits specified in Title 10, Code of Federal Regulations, Part 20, Subpart C, Sections 20.1201 through 20.1208 are not exceeded. 27. The licensee shall monitor occupational exposures to radiation and shall supply and require the use of individual monitoring devices by personnel as required by Title 10, Code of Federal Regulations, Part 20, Section 20.1502 (a). 28. The licensee shall monitor occupational intakes of radioactive material by, and assess the committed effective dose equivalent to, individuals who may have exceeded or are likely to exceed, the limits specified in Title 10, Code of Federal Regulations, Part 20, Section 20.1502 (b). Suitable and timely measurements used for determination of such internal exposures shall be performed as specified by Section 20.1204. 29. For a period not to exceed 60 days in any calendar year, a visiting physician is authorized to use licensed materials for human use under the terms of this license, provided the visiting physician: (a) Has the prior written permission of the hospital's Administrator and its Radiation Safety Committee. (b) Is specifically named as a user on a U.S. Nuclear Regulatory Commission, an Agreement State or a Licensing State license authorizing human use. (c) Performs only those procedures for which the physician is specifically authorized by the U.S. Nuclear Regulatory Commission, an Agreement State or a Licensing State license. The licensee shall maintain for inspection copies of the written permission specified in (a) above and the licensee(s) specified in (b) and (c) above. These records shall be maintained for five years from the time the licensee grants its permission under (a) above.